HYOSCINE BUTYLBROMIDE — all Canadian products
8 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is HYOSCINE BUTYLBROMIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02512335 | ACCEL-HYOSCINE | ACCEL PHARMA INC | Tablet | Oral | HYOSCINE BUTYLBROMIDE 10 MG | Marketed | |
| 00363812 | BUSCOPAN | SANOFI CONSUMER HEALTH INC | Tablet | Oral | HYOSCINE BUTYLBROMIDE 10 MG | Marketed | |
| 00363839 | BUSCOPAN | SANOFI CONSUMER HEALTH INC | Solution | Intravenous; Subcutaneous; Intramuscular | HYOSCINE BUTYLBROMIDE 20 MG | Marketed | |
| 02282089 | BUSCOPAN INJECTION FOR HORSES | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | Intravenous | HYOSCINE BUTYLBROMIDE 20 MG | Marketed | |
| 02229868 | HYOSCINE BUTYLBROMIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intramuscular; Intravenous | HYOSCINE BUTYLBROMIDE 20 MG | Marketed | |
| 02560984 | HYOSCINE BUTYLBROMIDE INJECTION | AS KALCEKS | Solution | Intravenous; Intramuscular; Subcutaneous | HYOSCINE BUTYLBROMIDE 20 MG | Approved | |
| 02508419 | HYOSCINE BUTYLBROMIDE INJECTION BP | OMEGA LABORATORIES LIMITED | Solution | Subcutaneous; Intravenous; Intramuscular | HYOSCINE BUTYLBROMIDE 20 MG | Marketed | |
| 00363820 | BUSCOPAN SUP 10MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Suppository | Rectal | HYOSCINE BUTYLBROMIDE 10 MG | Cancelled Post Market |
Browse other molecules: